$XMTR

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

Xometry's stock rose due to an expanded partnership with TradeCentric and the launch of an AI-driven Workcenter, following record Q2 results. The company aims to strengthen its digital manufacturing platform, but remains unprofitable with debt.

Xometry Inc. (NASDAQ:XMTR) expanded its partnership with TradeCentric, adding Purchase Order Automation and Invoice Automation to its eProcurement systems. The integration supports over 220 solutions, including Coupa and SAP Ariba, aiming to streamline purchasing and invoicing processes. Xometry's CEO highlighted the importance of digital infrastructure for custom manufacturing. The service is available in the U.S., with plans for international expansion.

Xometry (XMTR) presented at the Goldman Sachs Communacopia + Technology Conference 2026, highlighting its growth strategy in custom manufacturing. The company reported 45% growth, 21% revenue per buyer increase, and a $275 billion market with 1% online penetration. Xometry plans a deep Siemens integration in 2027 and maintains a 35-40% gross margin target.

Xometry launched its next-gen Workcenter for manufacturing partners, featuring AI-driven job matching, improved performance tracking, and faster payment access. The redesign includes a new homepage and Job Board, reducing job review time by 60% and increasing acceptance rates by 15% in early tests, according to the company.

Altschuler Randolph sold 10,000 indirectly-held shares of Xometry, Inc. (XMTR) at an average of $90.82 ($90.47–$92.09, $0.91M total) across 3 trades on 2026-09-01 under a Rule 10b5-1 trading plan.

Xometry director Katharine Weymouth sold 10,000 shares for $947,668 in August 2026, following option exercises. Xometry's stock has risen 87% in a year, with a $5.31B market cap. The company reported Q2 2026 earnings beating estimates, with JPMorgan initiating coverage with an overweight rating and $120 target.

Weymouth Katharine sold 10,000 shares of Xometry, Inc. (XMTR) at an average of $94.77 ($94.30–$95.23, $0.95M total) across 2 trades over 2026-08-28 to 2026-08-31.

Xometry Inc's (XMTR) CTO sold 5,000 shares at $96.77 each, totaling $483,850. He now owns 135,777 shares. Over the past year, he sold 18,171 shares and bought none. Xometry's stock is trading at a 2.06x premium to its intrinsic value estimate, according to GuruFocus.

Raghavan Vaidyanathan (Chief Technology Officer) sold 5,000 shares of Xometry, Inc. (XMTR) at $96.76 ($0.48M total) on 2026-08-27.